Pab pawg kws kho mob Fab Kis Sanofi tau hais rau hnub Monday tias nws yuav yuav Provention Bio, Inc., lub tuam txhab biopharmaceutical US-based tsom rau cov kab mob autoimmune, rau $ 25 ib feem ntawm cov nyiaj ntsuab, hauv kev cog lus nrog tus nqi sib npaug ntawm $ 2.9 billion. Qhov kev pom zoo yuav tso cai rau Sanofi ntxiv rau nws cov ntaub ntawv, TZIELD, uas yog pom zoo hauv Asmeskas xyoo tas los raws li thawj tus kab mob-hloov kho kho rau ncua sij hawm ntawm theem 3 mob ntshav qab zib hom 1 (T1D). Provention tau tshaj tawm xyoo tas los kev pom zoo nrog Sanofi los koom tes txhawb kev kho mob hauv Asmeskas.
Source: https://www.marketwatch.com/story/sanofi-to-buy-provention-bio-in-deal-worth-2-9-billion-a159cb36?siteid=yhoof2&yptr=yahoo